DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1

Clinical trials for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1 explained in plain language.

Never miss a new study

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1 trials appear

Sign up with your email to follow new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for controlling devastating childhood seizures

Disease control Recruiting now

This Phase 3 trial is testing whether a new drug called relutrigine can safely reduce seizure frequency in children and adults with a severe form of epilepsy called developmental and epileptic encephalopathy (DEE). About 160 participants will receive either the drug or a placebo …

Matched conditions: DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1

Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1 trials appear

New hope for controlling devastating childhood seizures